The 2021 Q3 Biopharma Confidence Index Panel Discussion
Watch Kineticos’ most recent Biopharma Confidence Index below. Our moderator and panelists discussed the key findings and insights, including a...
Reimbursement Information Through Primary Research
Nathan Finger, former Director of Operations and current Director at Kineticos Ventures, and Abe Maingi, Former VP of Precision Medicine and current...
Deal Structure and Asset Valuation
A conversation with Philip Gialenios, former President and Chief Commercial Officer, and Nathan Finger, former Director of Operations and current...
The Value of Primary Research
What is primary research and why is it important to the life sciences industry? Abe Maingi, former VP of Precision Medicine and current head of...
How to Have a Successful Licensing Program
What is a licensing program and why is it important to the life sciences industry? Nathan Finger, former Director of Operations and current Director...
Increasing Patient Engagement Through Decentralized Clinical Research
Our December panel discussion is about “Increasing Patient Engagement Through Decentralized Clinical Research.” Our group of expert panelists from...
The State of Gene Editing Technologies and CRISPR
Join the conversation with our panel of Life Sciences industry experts as they discuss the current state of gene editing technologies and CRISPR....
What are Post-COVID-19 Implications to Corporate Strategy?
Join our panel of industry leaders from GeneCentric, Adjuvance Technologies, Locus Biosciences, and Kineticos as they look at Post COVID-19...
Subscribe To Our Knowledge Center
Free access to all of our content including articles, whitepapers, and Biopharma CEO confidence reports, and more.